Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials

Patient-level data from 2 phase III studies in patients with previously untreated, advanced-stage, nonsquamous non–small cell lung cancer (NSCLC) were pooled to examine outcomes with bevacizumab and chemotherapy based on age. METHODS: Data from patients randomized to paclitaxel–carboplatin (PC)+beva...

Descripción completa

Detalles Bibliográficos
Autores principales: Langer, Corey J., Socinski, Mark A., Patel, Jyoti D., Sandler, Alan B., Schiller, Joan H., Leon, Larry, Hazard, Sebastien J., Ramalingam, Suresh S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Articles: Thoracic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016219/
https://www.ncbi.nlm.nih.gov/pubmed/25628268
http://dx.doi.org/10.1097/COC.0000000000000163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016219/
https://www.ncbi.nlm.nih.gov/pubmed/25628268
http://dx.doi.org/10.1097/COC.0000000000000163

Ejemplares similares